David M. Ritchie

731 total citations
23 papers, 573 citations indexed

About

David M. Ritchie is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, David M. Ritchie has authored 23 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Pharmacology and 4 papers in Molecular Biology. Recurrent topics in David M. Ritchie's work include Pharmacogenetics and Drug Metabolism (5 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Inflammatory mediators and NSAID effects (3 papers). David M. Ritchie is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Inflammatory mediators and NSAID effects (3 papers). David M. Ritchie collaborates with scholars based in United States and Israel. David M. Ritchie's co-authors include Sean Peng, John A. Masucci, William Hageman, Gary W. Caldwell, Zhengyin Yan, Dennis Argentieri, Robert J. Capetola, J.L. McGuire, Marvin E. Rosenthale and Do Won Hahn and has published in prestigious journals such as The Journal of Immunology, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

David M. Ritchie

23 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Ritchie United States 14 169 167 95 76 57 23 573
J. Y. GAUTHIER Canada 11 218 1.3× 240 1.4× 118 1.2× 62 0.8× 109 1.9× 20 582
Kevin N. Dack United Kingdom 12 221 1.3× 260 1.6× 114 1.2× 48 0.6× 99 1.7× 22 683
William Hageman United States 13 234 1.4× 212 1.3× 63 0.7× 74 1.0× 44 0.8× 33 610
Anne Misher United States 11 89 0.5× 161 1.0× 93 1.0× 70 0.9× 88 1.5× 18 597
Nicholas Stock United States 14 187 1.1× 206 1.2× 138 1.5× 72 0.9× 77 1.4× 28 611
Norbert Knebel Germany 15 148 0.9× 303 1.8× 64 0.7× 91 1.2× 141 2.5× 24 771
Jennifer B. Bouska United States 15 206 1.2× 223 1.3× 145 1.5× 23 0.3× 54 0.9× 27 628
Alessandro Subissi Italy 14 174 1.0× 301 1.8× 68 0.7× 32 0.4× 40 0.7× 73 751
Kaushik Mitra United States 15 228 1.3× 197 1.2× 40 0.4× 126 1.7× 56 1.0× 31 516
Carl Berthelette Canada 19 428 2.5× 200 1.2× 84 0.9× 52 0.7× 60 1.1× 25 705

Countries citing papers authored by David M. Ritchie

Since Specialization
Citations

This map shows the geographic impact of David M. Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Ritchie more than expected).

Fields of papers citing papers by David M. Ritchie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Ritchie. The network helps show where David M. Ritchie may publish in the future.

Co-authorship network of co-authors of David M. Ritchie

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Ritchie. A scholar is included among the top collaborators of David M. Ritchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Ritchie. David M. Ritchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jain, Nareshkumar, Jiayi Xu, Ramesh M. Kanojia, et al.. (2009). Identification and Structure−Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms. Journal of Medicinal Chemistry. 52(23). 7544–7569. 90 indexed citations
3.
Peng, Sean, et al.. (2006). Altered Oral Bioavailability and Pharmacokinetics of P-Glycoprotein Substrates by Coadministration of Biochanin A. Journal of Pharmaceutical Sciences. 95(9). 1984–1993. 41 indexed citations
4.
Caldwell, Gary W., et al.. (2005). The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens. European Journal of Drug Metabolism and Pharmacokinetics. 30(1-2). 75–83. 9 indexed citations
5.
Peng, Sean, et al.. (2005). A 96-Well Screen Filter Plate for High-Throughput Biological Sample Preparation and LC−MS/MS Analysis. Analytical Chemistry. 78(1). 343–348. 14 indexed citations
6.
Weidner‐Wells, Michele A., Todd C. Henninger, Stephanie A. Fraga‐Spano, et al.. (2004). Synthesis and structure–activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(16). 4307–4311. 33 indexed citations
7.
Peng, Sean, et al.. (2003). High‐throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns. Rapid Communications in Mass Spectrometry. 17(6). 509–518. 36 indexed citations
8.
Caldwell, Gary W., Zhengyin Yan, John A. Masucci, et al.. (2003). Applied Pharmacokinetics in Drug Development. 1(2). 117–132. 4 indexed citations
9.
Caldwell, Gary W., David M. Ritchie, John A. Masucci, William Hageman, & Zhengyin Yan. (2001). The New Pre-Preclinical Paradigm: Compound Optimization in Early and Late Phase Drug Discovery. Current Topics in Medicinal Chemistry. 1(5). 353–366. 102 indexed citations
10.
Ritchie, David M., et al.. (2000). [19] Robotic assay of sphingomyelinase activity for high throughput screening. Methods in enzymology on CD-ROM/Methods in enzymology. 311. 168–176. 11 indexed citations
11.
Connolly, Peter J., Steven K. Wetter, Michael P. Wachter, et al.. (1999). N-Hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase. Bioorganic & Medicinal Chemistry Letters. 9(7). 979–984. 33 indexed citations
12.
Dodd, John H., Charles F. Schwender, John B. Moore, et al.. (1998). Design and discovery of RWJ 22108--a novel bronchoselective calcium channel blocker.. PubMed. 15(3). 135–48. 3 indexed citations
13.
Beers, Scott A., Elizabeth A. Malloy, Wei Wu, et al.. (1997). N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase. Bioorganic & Medicinal Chemistry. 5(4). 779–786. 29 indexed citations
14.
Anderson, David W., et al.. (1994). Reticulocyte measurements as a bioassay for erythropoietin. Journal of Pharmaceutical and Biomedical Analysis. 12(4). 515–522. 7 indexed citations
15.
Zhou, Li, et al.. (1994). Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.. The Journal of Immunology. 153(11). 5026–5037. 21 indexed citations
16.
Ritchie, David M., Thomas Kirchner, John B. Moore, et al.. (1993). Experimental Antiasthmatic Activity of RWJ 22108: A Bronchoselective Calcium Entry Blocker. International Archives of Allergy and Immunology. 100(3). 274–282. 3 indexed citations
17.
Phillips, A., D.W. Hahn, J.L. McGuire, et al.. (1988). Evaluation of the anaphylactoid activity of a new LHRH antagonist. Life Sciences. 43(11). 883–888. 19 indexed citations
18.
Dubinsky, Barry, et al.. (1984). Flunarizine and verapamil: Effects on central nervous system and peripheral consequences of cytotoxic hypoxia in rats. Life Sciences. 34(13). 1299–1306. 13 indexed citations
19.
Ritchie, David M., et al.. (1981). SRSA-mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo. Inflammation Research. 11(4). 396–401. 40 indexed citations
20.
Ritchie, David M., et al.. (1979). The cat as a model for myocardial infarction. Cardiovascular Research. 13(4). 199–206. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Y. GAUTHIER Breakdown of academic impact, for papers by Kevin N. Dack Breakdown of academic impact, for papers by William Hageman Breakdown of academic impact, for papers by Anne Misher Breakdown of academic impact, for papers by Nicholas Stock Breakdown of academic impact, for papers by Norbert Knebel Breakdown of academic impact, for papers by Jennifer B. Bouska Breakdown of academic impact, for papers by Alessandro Subissi Breakdown of academic impact, for papers by Kaushik Mitra Breakdown of academic impact, for papers by Carl Berthelette
Rankless by CCL
2026